Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Philadelphia Displays Many Facets of the Healthcare Debate

David S. Pisetsky, MD, PhD  |  Issue: January 2010  |  January 1, 2010

Intrigued, I stopped at the corner of 12th Street as waves of women in pink jackets, lace tutus, and billowing skirts came down Market Street under their umbrellas. Despite the pelting rain, the women seemed in high spirits, walking jauntily as they engaged in happy and animated conversation. I knew that this had to be a fundraiser of some kind and went up to one of the women to ask about the cause. The woman was middle-aged and was wearing a jacket slick with water. On the jacket were tens of tags with the names of women who were no doubt victims of disease.

The woman explained to me that this walk was to raise money for breast cancer research. The original plan called for three days of twenty miles each but, with the cold blast of the Nor’Easter, the organizers shortened it to one in the interest of safety. The goal for each woman was to raise $2,000. I figured that, with 2,500 walkers, the total gain would be about $5 million. While a lofty sum, $5 million is a drop in the research bucket of the NIH or that of any pharmaceutical company.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

While I initially felt sad for these women as they trekked through downtown into a wall of driving rain, I soon became happy as I realized that they were making as strong a statement for the value of research as any I heard at the ACR meeting. These women had the right priorities. They knew what research can do and were prepared to give their all on a rain-drenched Sunday morning to make their contribution.

Whatever changes occur in the healthcare system, I hope that they meet the hopes and aspirations of those women, and no doubt millions of Americans, who, like the founders of the ACR, want better healthcare and are willing to sacrifice to make it happen.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pisetsky is physician editor of The Rheumatologist and professor of medicine and immunology at Duke University Medical Center in Durham, N.C.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyOpinionProfessional TopicsResearch RheumRheuminationsSpeak Out Rheum Tagged with:AC&RAdvocacyHealthcareHealthcare ReformLegislationPatientsResearch

Related Articles

    Do RA Patients in Clinical Trials for Biologics Represent the Average?

    October 4, 2016

    It’s estimated that a majority of patients with rheumatoid arthritis (RA) have been exposed to biologic treatments. However, the randomized controlled trials demonstrating the safety and efficacy of these biologic agents have strict participant eligibility requirements. New research has examined the requirements of 30 trials for biologics and applied those standards to two large clinical cohorts. The result: A majority of these RA patients did not satisfy the criteria…

    University of Nebraska Division of Rheumatology and Immunology Makes Education, Clinical Research Top Priorities

    August 13, 2017

    When it was created in 1982, the Division of Rheumatology and Immunology at the University of Nebraska Medical Center comprised one-and-a-half rheumatologists: its founder, Lynell W. Klassen, MD, MACR, and Gerald Moore, MD, who later received formal training at the NIH and now serves as senior associate dean for academic affairs. Thirty-five years later, the…

    Doused in Denmark

    August 1, 2009

    EULAR captured the complex picture of rheumatology’s future

    Is It Cold in Here? Working in Cold Environments Linked to RA

    February 14, 2018

    Novel research has linked cold environments—with snow, ice and overall frigid conditions—to an increased risk of developing rheumatoid arthritis. This research has many rheumatologists eager for more research that could aid patients and further the understanding of the disease…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences